Search - tctmd.com

Displaying 781 - 800 of 1033

Sort: Relevancy | Date

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Presentation TCT 2018

The Art of Presentation: A Fundamental Skill for Cardiologists in the Contemporary Era

Presenter: C. Michael Gibson, Mamas Mamas, Abdallah El Sabbagh

September 24, 2018

Presentation TCT 2018

The Top 10 Quality Metrics for Your Cath Lab

Presenter: Sunil V. Rao, Michael A. Kutcher

September 24, 2018

Presentation TCT 2018

Rise of the Planet of the Apps: The World of Mobile Applications for Cardiovascular Education

Presenter: C. Michael Gibson, Mamas Mamas, Annapoorna Kini

September 24, 2018

Presentation TCT 2018

Tweetbook Cardiovascular Interventions: A New On-line Community for Sharing

Presenter: C. Michael Gibson, Mamas Mamas, David L Fischman

September 24, 2018

Presentation TCT 2018

The Interventional Cardiology Tweetorial: Use of Social Media as an Educational Tool for Teaching Interventional Techniques

Presenter: C. Michael Gibson, Mamas Mamas, Michael P Savage

September 24, 2018

Presentation TCT 2018

The Dos and Donts of Social Media in Practice

Presenter: C. Michael Gibson, Mamas Mamas, Poonam Velagapudi

September 24, 2018

Presentation TCT 2018

Industry Perspective

Presenter: C. Michael Gibson, William H. Maisel, Campbell Rogers

September 22, 2018

Presentation TCT 2018

Clinician Scientist/Trialist Perspective

Presenter: C. Michael Gibson, William H. Maisel, James K. Min

September 22, 2018

Presentation TCT 2018

FDA Perspectives

Presenter: C. Michael Gibson, William H. Maisel, Mohua Choudhury

September 22, 2018

Presentation TCT 2018

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Presenter: C. Michael Gibson, William H. Maisel, Peter J. Fitzgerald

September 22, 2018

Advertisement

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

The Art of Presentation: A Fundamental Skill for Cardiologists in the Contemporary Era

The Top 10 Quality Metrics for Your Cath Lab

Rise of the Planet of the Apps: The World of Mobile Applications for Cardiovascular Education

Tweetbook Cardiovascular Interventions: A New On-line Community for Sharing

The Interventional Cardiology Tweetorial: Use of Social Media as an Educational Tool for Teaching Interventional Techniques

The Dos and Donts of Social Media in Practice

Industry Perspective

Clinician Scientist/Trialist Perspective

FDA Perspectives

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content